Updated: Sep 19, 2008
Cardiac rehabilitation aims to reverse limitations experienced by patients who have suffered the adverse pathophysiologic and psychological consequences of cardiac events.
Cardiovascular disorders are the leading cause of mortality and morbidity in the industrialized world, accounting for almost 50% of all deaths annually. The survivors constitute an additional reservoir of cardiovascular disease morbidity. In the United States alone, over 14 million persons suffer from some form of coronary artery disease (CAD) or its complications, including congestive heart failure (CHF), angina, and arrhythmias. Of this number, approximately 1 million survivors of acute myocardial infarction (MI), as well as the more than 300,000 patients who undergo coronary bypass surgery annually, are candidates for cardiac rehabilitation.
Traditionally, cardiac rehabilitation has been provided to somewhat lower-risk patients who could exercise without getting into trouble. However, astonishingly rapid evolution in the management of CAD has now changed the demographics of the patients who can be candidates for rehabilitation training. Currently, about 400,000 patients who undergo coronary angioplasty each year make up a subgroup that could benefit from cardiac rehabilitation. Furthermore, approximately 4.7 million patients with CHF are also eligible for a slightly modified program of rehabilitation, as are the ever-increasing number of patients who have undergone heart transplantation.1
This review addresses the objectives, indications, program components, exercise training, monitoring, benefits, risks, safety issues, outcome measures, and cost-effectiveness of cardiac rehabilitation.
The identification of the patients at risk for a cardiac event's recurrence (ie, risk stratification) is central to formulating an appropriate medical, rehabilitative, and surgical strategy to prevent such a recurrence. Patients who are at low or moderate risk typically undergo early rehabilitation. The major goals of a cardiac rehabilitation program are:
Cardiac rehabilitation programs have been consistently shown to improve objective measures of exercise tolerance and psychosocial well being without increasing the risk of significant complications.
The Agency for Health Care Policy and Research (AHCPR); the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), and the National Heart, Lung and Blood Institute (NHLBI) have recognized the wide variation in awareness and understanding of the role of cardiac rehabilitation among physicians, ancillary health care providers, third-party payers, and patients with heart disease.
In the past, it was found that only 11% of patients participated in such programs following an acute coronary event. However, there is evidence that participation has increased. Approximately 38% of US patients and 32% of Canadian patients with acute MI who were involved in the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial were enrolled in cardiac rehabilitation programs.
Current cardiac care has already reduced early acute coronary mortality so much so that further exercise training, as an "isolated" intervention, may not be able to cause significant reduction in the morbidity and mortality.2 Nonetheless, exercise training has the potential to act as a catalyst for promoting other aspects of rehabilitation, including risk factor modification through therapeutic lifestyle changes (TLC) and optimization of psychosocial support. Therefore, the outcome measures of cardiac rehabilitation now include improvement in quality of life (QOL), such as the patient's perception of physical improvement, satisfaction with risk factor alteration, psychosocial adjustments in interpersonal roles, and potential for advancement at work commensurate with the patient's skills (rather than simply return to work).3,4
Similarly, among patients who are elderly, such outcome measures may include the achievement of functional independence, the prevention of premature disability, and a reduction in the need for custodial care.5,6,7,8 Despite limited data, older male and female patients in observational studies have shown improvement in their exercise tolerance comparable to that of younger patients participating in equivalent exercise programs. In addition, the safety of exercise within cardiac rehabilitation programs, as studied in over 4,500 patients, is well accepted and established.
Cardiac rehabilitation services are, therefore, an effective and safe intervention. These services are undoubtedly an essential component of the contemporary treatment of patients with multiple presentations of coronary heart disease and heart failure.
Related eMedicine topics:
Angina Pectoris (Cardiology)
Angina Pectoris (Emergency Medicine)
Complications of Myocardial Infarction
Myocardial Infarction (Cardiology)
Myocardial Infarction (Emergency Medicine)
Myocardial Infarction in Childhood
Unstable Angina
Vascular Diseases and Rehabilitation
Related Medscape topics:
Resource Center Heart and Lung Transplant
Resource Center Heart Failure
In the 1930s, patients with myocardial infarction (MI) were advised to observe 6 weeks of bedrest. Chair therapy was introduced in the 1940s, and by the early 1950s, 3-5 minutes of daily walking was advocated, beginning at 4 weeks. Clinicians gradually began to recognize that early ambulation avoided many of the complications of bed rest, including pulmonary embolism (PE), and that it did not increase the risk. However, concerns about the safety of unsupervised exercise remained strong; this led to the development of structured, physician-supervised rehabilitation programs, which included clinical supervision, as well as electrocardiographic monitoring.
In the 1950s, Hellerstein presented his methodology for the comprehensive rehabilitation of patients recovering from an acute cardiac event.9 He advocated a multidisciplinary approach to the rehabilitation program. His approach was adopted by cardiac rehabilitation programs throughout the world. Despite multiple advances, Hellerstein's original ideas have not been improved upon significantly. However, due to changing patient demographics, many more patients now have the opportunity to receive the benefits offered by cardiac rehabilitation. Multifactorial intervention, including aggressive risk factor modification, has become an integral part of present day cardiac rehabilitation.
According to the US Public Health Service (USPHS), a cardiac rehabilitation program is defined as a program that involves the following:
Cardiac rehabilitation has to be comprehensive and, at the same time, individualized. The main goals of a cardiac rehabilitation program should include the following:
Coronary vasodilatation is mainly driven by the bioavailability of nitric oxide (NO), which is produced by the activities of the endothelially derived enzyme NO synthase and is metabolized by reactive oxygen species. This fine-tuned balance is disturbed in people with CAD. This form of impairment of NO production, along with excessive oxidative stress, results in the loss of endothelial cells via apoptosis. Further aggravation of endothelial dysfunction ensues, which triggers myocardial ischemia in persons with coronary artery disease (CAD). In healthy individuals, an increased release of NO from the vascular endothelium in response to exercise training results from changes in endothelial NO synthase expression, phosphorylation, and conformation.
By the same token, exercise training has assumed a role in the cardiac rehabilitation of patients with CAD, because it reduces mortality and increases myocardial perfusion. This has been largely attributed to the exercise training – mediated correction of coronary endothelial dysfunction in persons with CAD. In persons with CAD, regular physical activity leads to a restoration of the balance between NO production by NO synthase and NO inactivation by reactive oxygen species, thereby enhancing the vasodilatory capacity in various vascular beds.
Because endothelial dysfunction has been identified as a predictor of cardiovascular events, the partial reversal of endothelial dysfunction achieved by regular physical exercise appears to be the most likely mechanism behind the exercise training – induced reduction in cardiovascular morbidity and mortality in patients with CAD.
Cardiac rehabilitation encompasses short-term and long-term goals that are to be achieved through exercise, education, and counseling. Patients generally fall into following categories:
The short-term goals of cardiac rehabilitation include the restoration of the physical, psychological, and social condition, while the long-term goals involve the promotion of heart-healthy behaviors that enable the individual to return to productive and/or joyful vocational and avocational activities.
The cardiac rehabilitation programs benefit women and men equally.10 Elderly patients also can derive significant benefit from rehabilitation programs.
The risk stratification process is very valuable for cardiac patients; it serves as the basis for individualizing the prescription of exercise training and for assessing the need and extent of supervision required. The risk stratification process is based on the assessment of the patient's functional capacity, on the patient's educational and psychosocial status, on whether alternatives to traditional cardiac rehabilitation can be used, and on whether the patient is suffering from myocardial ischemia, ventricular dysfunction, or arrhythmias.
Functional capacity
The term functional capacity refers to the maximum ability of the heart and lungs to deliver oxygen and the ability of the muscles to extract it. Functional capacity is measured by determining the maximal oxygen uptake (VO2 max) during incremental exercise.
In most patients, a rough calculation of functional capacity can be performed by using multiples of 1 MET (metabolic equivalent, 3.5 mL O2 uptake/kg/min). In complicated patients, such as those with severe left ventricular (LV) dysfunction and congestive heart failure (CHF), the functional capacity can be ascertained with greater accuracy by using cardiopulmonary exercise (CPX) testing. Most cardiac rehabilitation facilities, however, are not currently equipped for CPX.
The following factors influence functional capacity:
Every attempt should be made to recognize the potential effects of these factors on functional capacity in order to minimize risk of the individualized reconditioning program that is being formulated.
Myocardial ischemia
Symptomatic or asymptomatic (silent) myocardial ischemia may limit the patient's exertional capacity by causing limiting angina, dyspnea, or fatigue.
Ventricular dysfunction
Fixed LV dysfunction or damage may be present in the absence of angina. Patients with LV dysfunction develop early dyspnea and easily become fatigued.
Cardiopulmonary exercise testing preferably should be performed to determine the functional capacity in an objective manner.
Exercise intolerance in patients with LV dysfunction is due to skeletal muscle hypoperfusion resulting from inadequate cardiac output that can be better quantified by measuring VO2 max.
Arrhythmias
Ventricular irritability and complex ventricular arrhythmias require assessment through the use of signal-averaged electrocardiogram (ECG) or electrophysiologic studies.
Appropriate medical or device treatments should be undertaken whenever feasible prior to beginning phase 2 of the cardiac rehabilitation program.
Very close surveillance is necessary in patients with significant cardiac arrhythmias during their exercise training routines. Concomitant rhythm monitoring with telemetry, Holter or event monitoring should be considered. In many cases of serious arrhythmias, therapy remains controversial and the safety of is exercise unclear; such uncertainties complicate the decision-making process.
Patients with severe ventricular arrhythmias and uncontrolled supraventricular arrhythmias should be excluded from exercise training unless proper evaluation and effective therapy has been instituted. Patients with devices, such as pacemakers and defibrillators, should be carefully monitored during exercise. Rate-responsive pacemakers are quite helpful even for those patients who are completely pacemaker-dependent. In case of implantable cardioverter defibrillators (ICDs), exercise training can be provided as long as underlying arrhythmias are controlled with pharmacotherapy. Heart rate should be kept well below the threshold at which the antitachycardia algorithm of the ICD begins.
Educational and psychosocial status
Approximately 20-25% of acute myocardial infarction (MI) patients demonstrate severe psychological stress or major depression; they also show higher morbidity and mortality.11 Clinically significant depressive symptoms are found in 40-65% of patients after an MI.
Exercise does provide some benefit, but severe cases may require specific therapy that has been shown to enhance the benefits derived from subsequent cardiac rehabilitation.
The promotion of self-efficacy and control over one's activities is of paramount importance for boosting self-confidence.
Coronary-prone behavior (CPB) is known as a cardiac risk factor, but its effect on prognosis is unclear. Some data suggest that the modification of CPB can improve the coronary disease prognosis.
Initially, continuous ECG monitoring is recommended for most patients during cardiac rehabilitation exercise training; however, clinicians may decide whether to use continuous or intermittent ECG monitoring. After the initial period, the use of electrocardiography depends on the clinical judgment of the supervising physician.
Alternative approaches to cardiac rehabilitation
In carefully selected patients, alternatives to the traditional supervised (group or individual) cardiac rehabilitation program have been examined. These alternatives, which are applicable primarily to very low-risk patients, include the following options:
Heart rate recovery (HRR) following maximal exercise has been found to be a predictor of all-cause mortality. In a 2006 study, Streuber and colleagues hypothesized that aerobic exercise training could improve HRR in patients who have suffered heart failure, because athletes are known to have accelerated HRR, while cardiac rehabilitation has been shown to positively effect such recovery in patients with coronary artery disease (CAD).12 The authors conducted a retrospective study of 46 patients with heart failure who had completed a phase 2 aerobic cardiac rehabilitation program with entry and exit maximal stress tests. The results indicated that in patients with heart failure who have low exercise capacity, even short-term aerobic training can aid HRR.
Cardiac rehabilitation initially was designed for low-risk cardiac patients. Now that the efficacy and safety of exercise have been documented in patients previously stratified to the high-risk category, such as those with congestive heart failure (CHF), the indications have been expanded to include such patients. Exercise training benefits persons with the following cardiac conditions:
Exercise prescription depends on the results of exercise testing, which often includes cardiopulmonary exercise (CPX) testing.
Patients with limitations due to chronic obstructive pulmonary disease (COPD), peripheral vascular disease (PVD), stroke, and orthopedic conditions still can be trained in the exercises through special techniques and adaptive equipment (eg, use of arm-crank ergometer).
Cardiac rehabilitation services are contraindicated in patients with the following conditions:
In such patients, every effort should be made to correct these abnormalities through optimization of medical therapy, revascularization by angioplasty or bypass surgery, or electrophysiologic testing and subsequent antiarrhythmic drug or device therapy. Patients should then undergo retesting for exercise prescription.
Two forms of exercise tests are performed in patients following an acute cardiac event: submaximal exercise testing and symptom-limited exercise testing. Furthermore, CPX also may be performed, particularly in patients with cardiomyopathy or CHF, to determine objectively the patient's exercise capacity.
Submaximal exercise testing is not necessarily safer than symptom-limited testing. In fact, the submaximal strategy may have certain disadvantages; it can lead to inappropriate limitation in the patient's routine activities and exercise training and to a significant delay in the patient's return to work. The use of submaximal exercise may also result in a failure to elicit important factors in prognosis, such as ischemia, cardiac dysfunction, and arrhythmia.
Phase 2 of a cardiac rehabilitation program is initiated based on the result of the exercise testing, and the exercise prescription is individualized. Three main components of an exercise training program are as follows:
Exercise initiation
Exercise sessions should begin with 10 minutes of warm-up, during which light calisthenics and muscular stretching are performed to avoid muscle injury and to bring about a graded increase in heart rate. This warm-up period is followed by 40 minutes of aerobic exercise (eg, walking, jogging, bicycling) and a final 10 minutes of cool-down period involving muscular stretching. The cool-down period is very important. Gradual cool-down prevents ventricular arrhythmias, which may occur in patients with coronary disease on abrupt cessation of exercise.
Progression
The patient's peak heart rate is noted. The target is, subsequently, increased by 5-10% of the peak heart rate until the patient is able to exercise at 85% of the peak heart rate. Most patients are able to do so by 2-3 months. A follow-up treadmill test should be performed at 4-8 weeks after the patient starts the program, and the result should be used to fine-tune the exercise training.
Special considerations
In patients with myocardial ischemia, exercise training still can be performed safely. The maximal heart rate should be kept 10 beats per minute (bpm) lower than the heart rate at which ischemia occurred. Closer surveillance and ECG monitoring are recommended in patients following myocardial ischemia. Patients with arrhythmias also need ECG monitoring. Patients with CHF require a much more modified exercise program.
Related Medscape topic:
CME/CE Aerobic Plus Resistance Training May Improve Coronary Artery Disease Outcomes
CME/CE Risks and Benefits of Exercise Reviewed in AHA Statement
Cardiac rehabilitation services are divided into 3 phases, as follows:
Phase 1: in-hospital phase
Phase 1.5: postdischarge phase
Phase 2: supervised exercise
Phase 3: maintenance phase
Sexual activity
Related Medscape topics:
Resource Center Cardiometabolic Risk Factor Management
Resource Center Risk Factor Management
Cardiac rehabilitation provides many benefits for patients. The most important of these are discussed in this section.
Improved exercise tolerance
Cardiac rehabilitation exercise training for patients with coronary heart disease or congestive heart failure (CHF) leads to objectively verifiable improvement in exercise capacity in men and women, regardless of age.10 Adverse outcomes or complications of exercise are exceedingly rare. The nonfatal infarction rate is 1 patient per 294,000 patient-hours; the cardiac mortality rate is 1 patient per 784,000 patient-hours. The benefits are even greater in patients with diminished exercise tolerance. This beneficial effect does not persist long-term after completion of cardiac rehabilitation without a long-term maintenance program. Therefore, exercise training must be maintained long-term to sustain the improvement in exercise capacity.
Control of symptoms
In patients with coronary heart disease, angina significantly improves during the cardiac rehabilitation exercise program. Objective evidence of improvement in ischemia has been seen by performing interval stress ECG or radionuclide testing. Similarly, patients with LV failure or dysfunction show improvement in the symptoms of heart failure.15 Use of gas analysis (CPX) has shown that patients' exertional tolerance improves significantly with exercise training.
Improvement in the blood levels of lipids
Improvements in lipid and lipoprotein levels are observed in patients undergoing cardiac rehabilitation exercise training and education.16 Exercise must be combined with dietary and medical interventions for required lipid control.
Effect on body weight
Exercise training as a sole intervention has an inconsistent effect on controlling excess weight. Optimal management of obesity requires multifactorial rehabilitation, including nutritional education and counseling, behavioral modification, and exercise training.17
Effect on blood pressure
Rehabilitation exercise training as a sole intervention has minimal effect; however, multifactorial intervention has been shown to have beneficial effects. Inconsistencies with this theory remain unresolved.
Reduction in smoking
Cardiac rehabilitation services with well-designed educational, counseling, and behavioral modification programs result in cessation of smoking in a significant number of patients. Cessation of smoking can be expected in 16-26% of patients. This reduction is combined with the spontaneously high smoking cessation rates following acute coronary events.
Improved psychosocial well-being
Cardiac rehabilitation exercise and educational services enhance measures of psychological and social functioning.3,4
Reduction of stress
In multifactorial cardiac rehabilitation programs, improvement in emotional-stress measurements occurs, as does a reduction of type A behavior patterns. This reduction of stress is consistent with improvement in psychosocial outcomes that occurs in nonrehabilitation settings.
Enhanced social adjustment and functioning
Cardiac rehabilitation exercise training improves social adjustment and functioning.
Return to work
Cardiac rehabilitation exercise training exerts less influence on rates of return to work than on other aspects of life. Many nonexercise variables also affect this outcome (eg, prior employment status, employer attitude, economic incentives).
Reduced mortality
Scientific data suggest a survival benefit for patients who participate in cardiac rehabilitation exercise training, but it is not attributable to exercise alone. This survival benefit is due to multifactorial interventions. A meta-analysis of post–myocardial infarction (MI), randomized, controlled trials of exercise showed a 25% reduction in mortality at 3-year follow-up. The magnitude of this benefit is as large as that seen with the post-MI use of beta blockers or with the use of ACE inhibitors in LV dysfunction along with MI. Trials that involve exercise alone still show a 15% mortality reduction.
The scientific evidence pertaining to the relationship between cardiac rehabilitation exercise training and mortality also includes scientific reports that have appeared on the US National Institutes of Health Web site. Among the data in these reports was the finding, through randomized trial, that 3-year coronary mortality and sudden death rates were significantly lower (P <.02) in patients who, after suffering myocardial infarction, underwent multifactorial cardiac rehabilitation, starting 2 weeks after hospital discharge. This beneficial outcome persisted at the 10-year follow-up.
The larger center from a multicenter European trial of exercise-only rehabilitation in males (post-MI) reported significant mortality reduction in the rehabilitation group (P <.01).
Pathophysiologic measures
When combined with intensive dietary intervention, with or without lipid-lowering drugs, exercise training may result in the limitation of progression or in the regression of angiographically documented coronary atherosclerosis.
Exercise training in patients with heart failure and compromised LV ejection fraction produces favorable hemodynamic changes in the skeletal musculature. Therefore, cardiac rehabilitation exercise training is recommended for the improvement of skeletal muscle functioning. However, such training does not seem to improve cardiac hemodynamic function or collateral circulation to any significant degree.
Patients following cardiac transplantation
Following orthotropic cardiac transplantation, rehabilitation exercise training is recommended to improve patients' exercise tolerance measurements.14
Elderly patients and women
Coronary patients who are elderly have exercise trainability comparable to that of younger patients participating in similar rehabilitation programs. Elderly patients (male and female) show comparable improvements. Unfortunately, referrals to cardiac rehabilitation are made less frequently for elderly patients, particularly for elderly women; participation in cardiac rehabilitation also is less frequent among the elderly. No complications or adverse outcomes for elderly patients have been described in any study. Elderly male and female patients should be encouraged to participate in cardiac rehabilitation.
Patients on dialysis and following coronary artery bypass grafting surgery
Patients who are on renal dialysis are at high risk for cardiac death and have a large burden of cardiovascular disease and cardiovascular disease risk factors. Cardiac rehabilitation can promote improved survival of nondialysis patients after coronary artery bypass grafting (CABG) surgery and is covered by Medicare,13 but no studies have investigated whether dialysis patients' survival after CABG may be improved as a function of cardiac rehabilitation.
In a 2006 study by Kutner and colleagues, it was found that, in comparison with dialysis patients who did not undergo cardiac rehabilitation, there was a 35% risk reduction for all-cause mortality, as well as a 36% risk reduction for cardiac death, in dialysis patients who had cardiac rehabilitation following CABG; the findings were independent of sociodemographic and clinical risk factors, such as recent hospitalization.18 In the study, 10% of patients received cardiac rehabilitation after CABG, less than half the estimated share of patients in the general pouplation who such rehabilitation. Women and black patients aged 65 or older, along with lower-income patients of all ages, were significantly less likely to receive cardiac rehabilitation services. This observational study suggests that following CABG, cardiac rehabilitation increases a dialysis patient's likelihood of survival.
Exercise training involves certain risks, especially in patients with undiagnosed or undertreated myocardial ischemia, ventricular arrhythmias, or LV dysfunction. The intensity of exercise must be kept below the level of exercise at which the abnormalities were elicited during the risk stratification and testing phase.
The proper selection of patients is of paramount importance before phase 2 or phase 3 exercise programs are begun.19 Patients with certain characteristics are at a higher risk and therefore require all attempts at correction of the high-risk condition prior to exercise training. Patients also must be monitored with continuous electrocardiography and be supervised closely. High-risk factors include the following:
For some patients, the risks of exercise may outweigh the benefits. In these instances, patients should be counseled against exercise training, and their medical management must first be optimized with thorough supervision.
High-risk patients, constituting approximately 15-25% of all patients referred for cardiac rehabilitation, require the maximum level of supervision and surveillance, including continual ECG monitoring. The group of high-risk patients described above constitutes the bulk of such patients.
Intermediate-risk patients need somewhat less intense surveillance. The level of supervision needed includes unmonitored exercise training in groups in the presence of health professionals who are certified in advanced cardiac life support (ACLS).
Very low-risk patients can exercise safely and independently once they have learned how to monitor their pulse rates and are able to recognize warning signs. Such patients have greater than 8 METs of exercise capacity without symptoms or signs of angina, heart failure, or arrhythmias.
Alternative approaches to the traditional supervised cardiac rehabilitation programs have been evaluated and found to be reasonably safe. These off-site, self-monitored or telemetry-monitored programs are applicable primarily to very low-risk patients and include (1) home-based cardiac rehabilitation (effective and safe) and (2) exercise with trans-telephonic surveillance.
Supervised exercise training programs have extremely good safety records, despite the inherent potential for cardiovascular complications during exercise. None of the more than 3 dozen randomized controlled trials of cardiac rehabilitation exercise testing and training in patients with coronary heart disease, involving over 4,500 patients, showed any increase in morbidity or mortality in rehabilitation compared with control patient groups.
A 1980-1984 survey of 142 US cardiac rehabilitation programs reported a low rate of nonfatal myocardial infarction (MI; 1 case per 294,000 patient-hours) and cardiac mortality (1 case per 784,000 patient-hours). A total of 21 episodes of cardiac arrest occurred, with resuscitation successfully performed in 17 of these episodes. Therefore, the safety of exercise within cardiac rehabilitation programs is well accepted and established.
Cardiac rehabilitation, a clinically effective intervention for coronary heart disease, has been subjected to preliminary cost analyses.6,20 In a US study, a randomized, 8-week trial of rehabilitation beginning 6 weeks following MI showed a cost-effectiveness of $9,200 per quality adjusted life year. Subsequently, a similar analysis showed a cost-effectiveness of only $4,950 per year of life saved. In contrast, cholesterol lowering for secondary prevention has a cost-effectiveness of $9,630 per year of life saved, thrombolytic therapy for acute MI has a C/E of $32,700 per year of life saved, and bypass surgery has a cost-effectiveness of $18,700 for a year of life saved.
In Sweden, a comprehensive cost analysis of cardiac rehabilitation, performed on patients following MI or bypass surgery (with a 5-year follow-up), showed that rehospitalizations decreased from 16 to 11 days; the study also showed a higher rate of return to work (53% versus 38%). Overall, cardiac rehabilitation programs resulted in cost savings to the Swedish system of $12,000 per patient.
Research therefore indicates that cardiac rehabilitation is not only clinically effective, but is cost-effective as well. Cardiac rehabilitation compares favorably with other medical interventions performed commonly in patients with coronary heart disease.
Cardiac rehabilitation is an important component of the current multidisciplinary approach to the management of the patients with various presentations of coronary heart disease. Cardiac rehabilitation involves exercise training, education, counseling regarding risk reduction and lifestyle modification, and, frequently, behavior interventions.
The goals of cardiac rehabilitation services are to improve the physiologic and psychosocial condition of patients. Physiologic benefits include the improvement of exercise capacity and the reduction of risk factors (eg, cessation of smoking and lowering of lipid levels, body weight, blood pressure, blood glucose), with the exercise component provided through rehabilitation possibly reducing the progression of atherosclerosis. Psychological improvements include the reduction of depression, anxiety, and stress. All of these improvements enable the patient to acquire and maintain functional independence and to return to satisfactory and appropriate activity that benefits the patient and society.
For excellent patient education resources, visit eMedicine's Public Health Center. Also, see eMedicine's patient education articles Chest Pain, Coronary Heart Disease, Heart Attack, Walking for Fitness, and Resistance Training.
Grace SL, Gravely-Witte S, Brual J, et al. Contribution of patient and physician factors to cardiac rehabilitation referral: a prospective multilevel study. Nat Clin Pract Cardiovasc Med. Jun 10 2008;[Medline].
Brochu M, Poehlman ET, Savage P, et al. Modest effects of exercise training alone on coronary risk factors and body composition in coronary patients. J Cardiopulm Rehabil. May-Jun 2000;20(3):180-8. [Medline].
Ades PA, Coello CE. Effects of exercise and cardiac rehabilitation on cardiovascular outcomes. Med Clin North Am. Jan 2000;84(1):251-65, x-xi. [Medline].
Dugmore LD, Tipson RJ, Phillips MH, et al. Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme. Heart. Apr 1999;81(4):359-66. [Medline]. [Full Text].
Ferrara N, Corbi G, Bosimini E, et al. Cardiac rehabilitation in the elderly: patient selection and outcomes. Am J Geriatr Cardiol. Jan-Feb 2006;15(1):22-7. [Medline].
Lavie CJ, Milani RV. Cardiac rehabilitation and preventive cardiology in the elderly. Cardiol Clin. Feb 1999;17(1):233-42. [Medline].
Lavie CJ, Milani RV, Cassidy MM, et al. Benefits of cardiac rehabilitation and exercise training in older persons. Am J Geriatr Cardiol. Jul 1995;4(4):42-8. [Medline].
Taylor R, Kirby B. Cost implications of cardiac rehabilitation in older patients. Coron Artery Dis. 1999;10(1):53-6. [Medline].
Bethell HJ. Cardiac rehabilitation: from Hellerstein to the millennium. Int J Clin Pract. Mar 2000;54(2):92-7. [Medline].
Cannistra LB, Balady GJ, O'Malley CJ, et al. Comparison of the clinical profile and outcome of women and men in cardiac rehabilitation. Am J Cardiol. May 15 1992;69(16):1274-9. [Medline].
Casey E, Hughes JW, Waechter D, et al. Depression predicts failure to complete phase-II cardiac rehabilitation. J Behav Med. Aug 22 2008;[Medline].
Streuber SD, Amsterdam EA, Stebbins CL. Heart rate recovery in heart failure patients after a 12-week cardiac rehabilitation program. Am J Cardiol. Mar 1 2006;97(5):694-8. [Medline].
Herdy AH, Marcchi PL, Vila A, et al. Pre- and postoperative cardiopulmonary rehabilitation in hospitalized patients undergoing coronary artery bypass surgery: a randomized controlled trial. Am J Phys Med Rehabil. Sep 2008;87(9):714-9. [Medline].
Carrel T, Mohacsi P. Optimal timing of rehabilitation after cardiac surgery: the surgeon's view. Eur Heart J. Nov 1998;19 Suppl O:O38-41. [Medline].
Giallauria F, Galizia G, Lucci R, et al. Favourable effects of exercise-based cardiac rehabilitation after acute myocardial infarction on left atrial remodeling. Int J Cardiol. Aug 2 2008;[Medline].
Sarrafzadegan N, Rabiei K, Kabir A, et al. Changes in lipid profile of patients referred to a cardiac rehabilitation program. Eur J Cardiovasc Prev Rehabil. Aug 2008;15(4):467-72. [Medline].
Bader DS, Maguire TE, Spahn CM, et al. Clinical profile and outcomes of obese patients in cardiac rehabilitation stratified according to National Heart, Lung, and Blood Institute criteria. J Cardiopulm Rehabil. Jul-Aug 2001;21(4):210-7. [Medline].
Kutner NG, Zhang R, Huang Y, et al. Cardiac rehabilitation and survival of dialysis patients after coronary bypass. J Am Soc Nephrol. Apr 2006;17(4):1175-80. [Medline]. [Full Text].
Ambrosetti M, Salerno M, Ageno W, et al. Is physical training contraindicated in patients with deep vein thrombosis during cardiac rehabilitation?. Monaldi Arch Chest Dis. Mar 2005;64(1):24-6. [Medline].
Carlson JJ, Johnson JA, Franklin BA, et al. Program participation, exercise adherence, cardiovascular outcomes, and program cost of traditional versus modified cardiac rehabilitation. Am J Cardiol. Jul 1 2000;86(1):17-23. [Medline].
Ambrosetti M, Salerno M, Laporta A, et al. Metabolic syndrome in patients with intermittent claudication referred to vascular rehabilitation. Int Angiol. Mar 2006;25(1):14-7. [Medline]. [Full Text].
Cardiac Rehabilitation. Rockville, MD: US Department of Health and Human Services; Oct 1995. Clinical Practice Guidelines.
Cardiac rehabilitation programs. A statement for healthcare professionals from the American Heart Association. Circulation. Sep 1994;90(3):1602-10. [Medline].
Dennis C. Rehabilitation of patients with coronary artery disease. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, Pa: WB Saunders; 1997:1392-1403.
Flaker GC, Singh VN. Prevention of myocardial reinfarction. Recommendations based on results of drug trials. Postgrad Med. 1993;94(6):94-104. [Medline].
Fletcher GF. Current status of cardiac rehabilitation. Am Fam Physician. Nov 15 1998;58(8):1778-82. [Medline]. [Full Text].
Gohlke H, Gohlke-Bärwolf C. Cardiac rehabilitation. Eur Heart J. Jul 1998;19(7):1004-10. [Medline]. [Full Text].
Gordon NF, Haskell WL. Comprehensive cardiovascular disease risk reduction in a cardiac rehabilitation setting. Am J Cardiol. Oct 30 1997;80(8B):69H-73H. [Medline].
Hämäläinen H, Luurila OJ, Kallio V, et al. Long-term reduction in sudden deaths after a multifactorial intervention programme in patients with myocardial infarction: 10-year results of a controlled investigation. Eur Heart J. Jan 1989;10(1):55-62. [Medline].
Kallio V, Hämäläinen H, Hakkila J, et al. Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction. Lancet. Nov 24 1979;2(8152):1091-4. [Medline].
Kobashigawa JA, Leaf DA, Lee N, et al. A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med. Jan 28 1999;340(4):272-7. [Medline]. [Full Text].
Lamm G, Denolin H, Dorossiev D, et al. Rehabilitation and secondary prevention of patients after acute myocardial infarction. WHO collaborative study. Adv Cardiol. 1982;31:107-11. [Medline].
Lavie CJ, Milani RV. Cardiac rehabilitation, exercise training, and psychosocial risk factors. J Am Coll Cardiol. Jan 3 2006;47(1):212; author reply 212-3. [Medline].
Lavie CJ, Milani RV. Effects of cardiac rehabilitation programs on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in a large elderly cohort. Am J Cardiol. Jul 15 1995;76(3):177-9. [Medline].
Limacher MC. Exercise and cardiac rehabilitation in women. Cardiol Rev. Jul 1998;6(4):240-8. [Medline].
Linke A, Erbs S, Hambrecht R. Exercise and the coronary circulation-alterations and adaptations in coronary artery disease. Prog Cardiovasc Dis. Jan-Feb 2006;48(4):270-84. [Medline].
Maier W, Meier B. Interventional cardiology in perspective: impact on cardiac rehabilitation. Eur Heart J. Nov 1998;19 Suppl O:O24-8. [Medline].
Mark DB, Naylor CD, Hlatky MA, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. Oct 27 1994;331(17):1130-5. [Medline]. [Full Text].
Mochari H, Lee JR, Kligfield P, et al. Ethnic differences in barriers and referral to cardiac rehabilitation among women hospitalized with coronary heart disease. Prev Cardiol. 2006;9(1):8-13. [Medline].
Moore SM, Charvat JM, Gordon NH, et al. Effects of a CHANGE intervention to increase exercise maintenance following cardiac events. Ann Behav Med. Feb 2006;31(1):53-62. [Medline].
Oldridge N, Guyatt G, Crowe J, et al. Goal attainment in a randomized controlled trial of rehabilitation after myocardial infarction. J Cardiopulm Rehabil. Jan-Feb 1999;19(1):29-34. [Medline].
Sanderson BK, Bittner V. Women in cardiac rehabilitation: outcomes and identifying risk for dropout. Am Heart J. Nov 2005;150(5):1052-8. [Medline].
Sharma RK, Singh VN, Flaker GC. Signal-averaged electrocardiogram: a non-invasive diagnostic tool for arrhythmia management. Develop Cardiol. 1994;4(12):175-92.
Singh VN. The role of gas analysis with exercise testing. Prim Care. Mar 2001;28(1):159-79 ,vii-viii. [Medline].
Stone JA, Arthur HM. Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention, second edition, 2004: executive summary. Can J Cardiol. Oct 2005;21 Suppl D:3D-19D. [Medline].
cardiac rehabilitation, cardiac rehab, rehabilitation care, cardiovascular disease, congestive heart failure, arrhythmia, arrhythmias, heart attack, cardiac arrhythmia, heart arrhythmia, cardiac arrhythmias, heart arrhythmias, cardiac arrest, cardiac rehabilitation program, cardiac rehab program, heart problems, coronary artery disease, angina, myocardial infarction, cardiac event, cardiac events, cardiac rehabilitation exercise, rehabilitation after heart attack, rehabilitation after bypass surgery, rehabilitation in patients with heart disease, exercise and heart disease
Vibhuti N Singh, MD, MPH, FACC, FSCAI, Director, Suncoast Cardiovascular Center; Chair, Cardiology Division and Cath Labs, Department of Medicine, Bayfront Medical Center; Clinical Assistant Professor, Division of Cardiology, University of South Florida College of Medicine
Vibhuti N Singh, MD, MPH, FACC, FSCAI is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Heart Association, American Medical Association, and Florida Medical Association
Disclosure: Nothing to disclose.
Douglas D Schocken, MD, FACC, FACP, Courtesy Professor, Department of Gerontology, University of South Florida College of Arts and Sciences; Professor, Departments of Medicine and Epidemiology and Biostatistics, University of South Florida College of Medicine
Douglas D Schocken, MD, FACC, FACP is a member of the following medical societies: American College of Cardiology and American College of Physicians
Disclosure: Nothing to disclose.
Karen Williams, MD, Medical Director, Bayfront Rehabilitation Services, Bayfront Medical Center
Karen Williams, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Medical Women's Association, American Spinal Injury Association, Florida Medical Association, Florida Society of Physical Medicine and Rehabilitation, and Southern Medical Association
Disclosure: Nothing to disclose.
Robert Stamey, Jr, BS, Manager, Department of Cardiopulmonary Rehabilitation, Bayfront Medical Center
Robert Stamey, Jr, BS is a member of the following medical societies: American College of Sports Medicine
Disclosure: Nothing to disclose.
Robert J Kaplan, MD, Associate Professor, Department of Physical Medicine and Rehabilitation, University of Kansas School of Medicine and Medical Center
Robert J Kaplan, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, Association of Academic Physiatrists, International Spine Intervention Society, and Physiatric Association of Spine, Sports and Occupational Rehabilitation
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Richard Salcido, MD, Chairman, Erdman Professor of Rehabilitation, Department of Physical Medicine and Rehabilitation, University of Pennsylvania School of Medicine
Richard Salcido, MD is a member of the following medical societies: American Academy of Pain Medicine, American Academy of Physical Medicine and Rehabilitation, American College of Physician Executives, American Medical Association, and American Paraplegia Society
Disclosure: Nothing to disclose.
Kelly L Allen, MD, Regional Medical Director, IMX-Medical Management Services
Disclosure: Nothing to disclose.
Consuelo T Lorenzo, MD, Consulting Staff, Department of Physical Medicine and Rehabilitation, Alegent Health Care, Immanuel Rehabilitation Center
Consuelo T Lorenzo, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)